Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular profiling of driver events in metastatic uveal melanoma.
Karlsson J, Nilsson LM, Mitra S, Alsén S, Shelke GV, Sah VR, Forsberg EMV, Stierner U, All-Eriksson C, Einarsdottir B, Jespersen H, Ny L, Lindnér P, Larsson E, Olofsson Bagge R, Nilsson JA. Karlsson J, et al. Among authors: jespersen h. Nat Commun. 2020 Apr 20;11(1):1894. doi: 10.1038/s41467-020-15606-0. Nat Commun. 2020. PMID: 32313009 Free PMC article.
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma.
Einarsdottir BO, Karlsson J, Söderberg EMV, Lindberg MF, Funck-Brentano E, Jespersen H, Brynjolfsson SF, Olofsson Bagge R, Carstam L, Scobie M, Koolmeister T, Wallner O, Stierner U, Berglund UW, Ny L, Nilsson LM, Larsson E, Helleday T, Nilsson JA. Einarsdottir BO, et al. Among authors: jespersen h. Cell Death Dis. 2018 Jul 24;9(8):810. doi: 10.1038/s41419-018-0865-6. Cell Death Dis. 2018. PMID: 30042422 Free PMC article.
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study.
Jespersen H, Olofsson Bagge R, Ullenhag G, Carneiro A, Helgadottir H, Ljuslinder I, Levin M, All-Eriksson C, Andersson B, Stierner U, Nilsson LM, Nilsson JA, Ny L. Jespersen H, et al. BMC Cancer. 2019 May 2;19(1):415. doi: 10.1186/s12885-019-5623-3. BMC Cancer. 2019. PMID: 31046743 Free PMC article. Clinical Trial.
Real-world data on PD-1 inhibitor therapy in metastatic melanoma.
Arheden A, Skalenius J, Bjursten S, Stierner U, Ny L, Levin M, Jespersen H. Arheden A, et al. Among authors: jespersen h. Acta Oncol. 2019 Jul;58(7):962-966. doi: 10.1080/0284186X.2019.1620966. Epub 2019 May 31. Acta Oncol. 2019. PMID: 31151362
Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma.
Einarsdottir BO, Karlsson J, Söderberg EMV, Lindberg MF, Funck-Brentano E, Jespersen H, Brynjolfsson SF, Bagge RO, Carstam L, Scobie M, Koolmeister T, Wallner O, Stierner U, Berglund UW, Ny L, Nilsson LM, Larsson E, Helleday T, Nilsson JA. Einarsdottir BO, et al. Among authors: jespersen h. Cell Death Dis. 2020 Feb 6;11(2):99. doi: 10.1038/s41419-020-2301-y. Cell Death Dis. 2020. PMID: 32029719 Free PMC article.
65 results